Literature DB >> 26068571

Circumspectives: The Replacements.

Markus Heilig1, William A Carlezon2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26068571      PMCID： PMC4839529          DOI： 10.1038/npp.2015.82

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

Review 1.  Agonist Medications for the Treatment of Cocaine Use Disorder.

Authors:  S Stevens Negus; Jack Henningfield
Journal:  Neuropsychopharmacology       Date:  2014-12-11       Impact factor: 7.853

Review 2.  Neurobiology of addiction versus drug use driven by lack of choice.

Authors:  Serge H Ahmed; Magalie Lenoir; Karine Guillem
Journal:  Curr Opin Neurobiol       Date:  2013-02-18       Impact factor: 6.627

Review 3.  Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.

Authors:  R P Mattick; J Kimber; C Breen; M Davoli
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

4.  Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers.

Authors:  D R Jasinski; S Krishnan
Journal:  J Psychopharmacol       Date:  2008-07-17       Impact factor: 4.153

Review 5.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  Richard P Mattick; Courtney Breen; Jo Kimber; Marina Davoli
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

Review 6.  Nicotine replacement therapy for smoking cessation.

Authors:  L F Stead; R Perera; C Bullen; D Mant; T Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
  6 in total
  1 in total

1.  The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine.

Authors:  Anushree N Karkhanis; Thomas J R Beveridge; Bruce E Blough; Sara R Jones; Mark J Ferris
Journal:  Drug Alcohol Depend       Date:  2016-06-25       Impact factor: 4.492
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.